Related by context. All words. (Click for frequent words.) 74 ATL/TV# 73 mertansine 73 Aplidin 72 tiapamil 72 Phase Ib study 72 MEK inhibitor 71 YONDELIS 71 Archexin 71 RhuDex ® 71 Mipomersen 71 budesonide foam 71 liposomal formulation 71 IMA# 71 methylnaltrexone 71 CEQ# 71 INCB# [001] 71 Nanobody 71 GLP toxicology studies 71 Guanilib 71 PDE4 inhibitor 71 JAK inhibitor 71 Bicifadine 70 Xanafide 70 EndoTAG TM -1 70 Onconase 70 IgG1 monoclonal antibody 70 Spiegelmer ® 70 Annamycin 70 Azedra 70 Virulizin ® 70 IAP inhibitor 70 JAK inhibitors 70 Cloretazine 70 OvaRex ® MAb 70 Ceflatonin 70 Aviptadil 70 PrevOnco 70 investigational humanized monoclonal antibody 70 Virulizin R 70 PSMA ADC 70 Plicera 70 Phase #b/#a trial 70 receptor tyrosine kinase inhibitor 70 CBLC# 70 otelixizumab 70 BNC# 70 SNT MC# 70 oral prodrug 70 proteasome inhibitor 69 Squalamine 69 Panzem R 69 Phase Ib clinical 69 reslizumab 69 AKT inhibitor 69 histone deacetylase HDAC inhibitor 69 CCR9 antagonist 69 thalidomide Thalomid 69 Factor VIIa 69 antisense oligonucleotide 69 Panzem 69 elotuzumab 69 Aflibercept 69 PCK# 69 eniluracil 69 EOquin 69 MAGE A3 ASCI 69 antibody MAb 69 anticancer compound 69 vascular disrupting agent 69 targeted radiotherapeutic 69 metaglidasen 69 DXL# 69 EGS# 69 TBC# 69 lomitapide 69 isoform selective 69 FOLOTYN ® 69 CDK inhibitor 69 thymalfasin 69 tesmilifene 69 PF # [002] 69 alvespimycin 69 Aurexis 69 CCX# 69 huC# DM4 69 beta 1a 69 XmAb# 69 CD# antibody [001] 69 Amplimexon 69 erlotinib Tarceva 69 IRX 2 69 Vernakalant 69 Bezielle 69 HCV protease inhibitor 69 phase IIb trial 68 HuMax CD4 68 Davanat 68 AEG# 68 ATL# [002] 68 Traficet EN 68 PSN# [002] 68 immunotherapeutic vaccine 68 Ocrelizumab 68 RhuDex 68 Hedgehog antagonist 68 CytoFabTM 68 Dacogen decitabine 68 Laquinimod 68 orally bioavailable 68 hormone LHRH antagonist 68 Phase #b/#a clinical 68 aurora kinase 68 Phase Ib II 68 Phase IIb clinical trials 68 Alocrest 68 Prestara 68 Pertuzumab 68 DPX Survivac 68 BrachySil TM 68 HuMax EGFr 68 Amrubicin 68 triphendiol 68 mTOR inhibition 68 humanized anti 68 baminercept 68 CDP# 68 Argatroban 68 LHRH antagonist 68 gefitinib Iressa 68 PI3K/Akt pathway inhibitor 68 bardoxolone 68 OMP #M# 68 BAL# [002] 68 vidofludimus 68 HuLuc# 68 Allovectin 7 68 Sapacitabine 68 GeneICE 68 PHX# 68 protein kinase inhibitor 68 Phase #b/#a 68 small molecule Hedgehog 68 ENMD # 68 vascular disrupting agents 68 phase IIa clinical 68 atacicept 68 cannabinor 68 enzastaurin 68 Golimumab 68 HuMax CD# 68 favorable pharmacokinetic profile 68 midstage trials 68 pertuzumab 68 Pimavanserin 68 angiogenesis inhibitor 68 A3 adenosine receptor 68 TLR9 agonists 68 registrational trial 68 Onalta 68 Cloretazine ® 68 antisense drug 68 octreotide implant 68 ALN PCS 68 glucagon receptor 68 Troxatyl 68 Exherin TM 68 SAR# [002] 68 T#I [002] 68 AQ4N 68 HQK 68 VitiGam 68 TRO# 67 Virulizin 67 entinostat 67 CIMZIA ™ 67 PXD# 67 Symadex 67 Safinamide 67 Granulocyte Colony Stimulating Factor 67 Phase 2a trial 67 anticancer agent 67 Sym# 67 AP# [003] 67 multicenter Phase II 67 GAP #B# 67 S/GSK# 67 ACAPODENE 67 tanespimycin 67 RhuDex TM 67 phase IIb clinical 67 RhuDex R 67 nucleoside analog 67 bortezomib Velcade 67 PNT# 67 cMET 67 glucokinase activator 67 JAK1 67 Fodosine 67 Soliris eculizumab 67 Phase IIa trials 67 Menadione 67 BAY #-# 67 Dacogen injection 67 Fx #A 67 NVA# 67 E1 INT TM 67 CYT# QbG# 67 ARIKACE ™ 67 renin inhibitor 67 elacytarabine 67 LymphoStat B belimumab 67 Phase IIa trial 67 depsipeptide 67 UPLYSO 67 Phase Ib 67 ZFP TF 67 Prodarsan ® 67 immune modulating 67 Enzastaurin 67 mGluR2 NAM 67 CRD5 67 ASONEP 67 Proellex TM 67 trastuzumab DM1 67 DCCR 67 Proxinium TM 67 CA4P 67 riociguat 67 Ozarelix 67 ProSavin 67 chemically modified siRNA 67 midstage clinical 67 ulimorelin 67 #ME# 67 Novolimus 67 Dasatinib 67 optimal dosing regimens 67 selective androgen receptor modulator 67 Lu AA# 67 eprotirome 67 TRX1 67 NXL# 67 cytostatic 67 Relivar 67 Orazol 67 liposomal doxorubicin 67 PKC# 67 R#/MEM # 67 Protein Kinase C 67 Lixivaptan 67 GLPG# 67 Temsirolimus 67 CD# monoclonal antibody 67 Genasense ® oblimersen 67 AZD# 67 immune modulatory 67 MKC# MKC# PP 67 Velcade bortezomib 67 tubulin inhibitor 67 Diamyd ® 67 generation antisense inhibitor 67 Pafuramidine 67 Epratuzumab 67 IMiDs R 67 Personalized Immunotherapy 67 PEG SN# 67 CYT# potent vascular disrupting 67 OncoGel 67 Loramyc R 67 chemokine receptor 67 humanized monoclonal antibody 67 TKM ApoB 67 indibulin 67 Onrigin 67 efaproxiral 67 IL# PE#QQR 67 MAXY G# 67 ELND# 67 Aurora kinase 66 Alzhemed TM 66 EndoTAG 66 CR# vcMMAE 66 Plenaxis TM 66 PLK1 SNALP 66 intranasal formulation 66 Synavive 66 Omacetaxine 66 Mycograb 66 orally administered inhibitor 66 Phenoptin 66 personalized immunotherapy 66 AAG geldanamycin analog 66 Telatinib 66 Denufosol 66 Elagolix 66 antisense inhibitor 66 OncoVEX GM CSF 66 Hedgehog pathway inhibitor 66 topically administered 66 rxRNA 66 HCV polymerase 66 SAR# [004] 66 PRTX 66 Vidaza azacitidine 66 ALN TTR 66 DACH platinum 66 Capesaris 66 vemurafenib 66 selective modulator 66 Removab 66 VAPRISOL 66 Vicriviroc 66 brivaracetam 66 pradefovir 66 Triolex 66 Apoptone 66 Posiphen 66 vosaroxin 66 TG# [003] 66 CTAP# Capsules 66 Panzem R NCD 66 Elafin 66 anti angiogenic agent 66 Icatibant 66 pan HDAC inhibitor 66 rhIL 7 66 Solulin 66 PARP inhibitor 66 Evoltra ® 66 Resten NG 66 Luteinizing Hormone Releasing Hormone 66 acadesine 66 ularitide 66 Pyridorin 66 Vitaxin 66 Aryplase 66 multi kinase inhibitor 66 Elvitegravir 66 Ambrisentan 66 Trovax 66 regorafenib 66 novel VDA molecule 66 Degarelix 66 schizophrenia CIAS 66 NeuVax 66 Aurora Kinase 66 CGEN # 66 Scancell 66 fosbretabulin 66 TMC# [002] 66 novel peptide 66 tramiprosate 66 INCB# [002] 66 GRN# 66 preclinical efficacy 66 Gleevec imatinib mesylate 66 CRLX# 66 PI3K inhibitor 66 Dapagliflozin 66 AZILECT ® 66 ESBA# 66 Cetrorelix 66 OHR/AVR# 66 dirucotide 66 Nanobody ® 66 phase Ib 66 ISIS # 66 Tyrima 66 EOquin TM 66 Marqibo TM 66 dasatinib Sprycel ® 66 non nucleoside inhibitor 66 pharmacokinetic PK study 66 humanized antibody 66 Curaxin CBLC# 66 registrational 66 AEGR 66 JAK2 inhibitor 66 targeting CD# 66 therapeutic monoclonal antibodies 66 TREDAPTIVE 66 Amigal 66 ocrelizumab 66 Azacitidine 66 phase IIa 66 investigational therapies 66 Zemplar Capsules 66 sitaxsentan 66 PEGylated Fab fragment 66 abiraterone acetate 66 CIMZIA TM 66 Eniluracil 66 Pazopanib 66 PRT# 66 RSD# 66 corticosteroid dexamethasone 66 diarrhea predominant irritable 66 PSN# [001] 66 obatoclax 66 Alvesco R 66 pharmacokinetic PK 66 ZEVALIN ® 66 Fibrillex TM 66 ThermoDox R 66 Phase 1b clinical trials 66 Irinotecan 66 LY# [003] 66 Phase 1a clinical 66 Cinquil 66 Nexavar sorafenib 66 Phase IIa clinical 66 Phase IIIb clinical 66 inhaled AAT 66 ALN TTR# 66 MEK inhibitors 66 GW# [003] 66 farletuzumab 66 luteinizing hormone releasing 66 histone deacetylase HDAC 66 HepeX B 66 Firazyr 66 incyclinide 66 deforolimus 66 pediatric acute lymphoblastic 66 Tarvacin TM 66 Androxal TM 66 Anidulafungin 66 photoprotective drug 66 Daclizumab 66 CCR5 antagonist 66 ganetespib 66 EP #R 66 acyclovir Lauriad R 66 Hsp# Inhibitor 66 axitinib 66 ruxolitinib 66 HCV protease inhibitors 66 R#/MEM 66 Cloretazine R VNP#M 66 LymphoStat B TM 66 immatics 66 dacetuzumab 66 NP2 Enkephalin 66 synthetic retinoid 66 HSP# inhibitor 66 YONDELIS R 66 NV1FGF 66 Oglemilast 66 mTOR mammalian target 66 Reverset 66 Fulvestrant 66 IND submission 66 ospemifene 66 #D#C# 66 AeroLEF TM 66 Rescula 66 INS# [001] 66 Tasimelteon 66 GAMMAGARD 66 AERx iDMS 65 Cethrin 65 preclinically 65 Neuradiab 65 humanized monoclonal 65 ACOMPLIA R 65 lumiliximab 65 PNP inhibitor 65 TACI Ig 65 inhibit metastasis 65 mitogen activated ERK kinase 65 forodesine 65 novel therapeutic antibodies 65 romazarit 65 RNAi therapeutic targeting 65 Gleevec resistant 65 MGCD# [001] 65 Pradefovir 65 PEGylated interferon 65 Iluvien ® 65 ELACYT 65 romidepsin 65 KNS # 65 ara C 65 PS# [001] 65 ReN# 65 PEGPH# 65 Pirfenidone 65 Darinaparsin 65 Blinatumomab 65 HIF 1a 65 Flutiform TM 65 mGluR5 NAM 65 ISTODAX 65 oral picoplatin 65 cilengitide 65 Glypromate 65 Debio 65 PrevOnco ™ 65 Ecallantide 65 immunomodulating 65 DP b# 65 CRMD# 65 Phase Ia 65 GALNS 65 SCIB1 65 chimeric monoclonal antibody 65 BRAF inhibitor 65 EndoTAG TM 65 VivaGel ™ 65 Cloretazine R 65 DDP# 65 Catena ® 65 CoFactor 65 Lenocta 65 elvucitabine 65 Pralatrexate 65 nalbuphine ER 65 OvaRex MAb 65 teriflunomide 65 omacetaxine mepesuccinate 65 Asentar 65 dose escalation Phase 65 trabectedin 65 histone deacetylase inhibitor 65 Vandetanib 65 Vascugel 65 veltuzumab 65 oxidative stress inducer 65 SinuNase ™ 65 selective adenosine 65 APOPTONE 65 Darusentan 65 BrachySil 65 Elesclomol 65 VA# [002] 65 Aplidin R 65 Everolimus 65 non nucleoside HCV 65 humanised antibody 65 theranostic 65 Lupuzor 65 EndoTAGTM 1 65 Abiraterone acetate 65 Revlimid lenalidomide 65 tipifarnib 65 Enzyme Replacement Therapy 65 OMP #R# 65 Corlux 65 OXi# 65 lorvotuzumab mertansine 65 herpetic keratitis 65 pomalidomide 65 drug GAP #B# 65 Cutanea 65 Janus Kinase 65 rilonacept 65 Desmoteplase 65 Clavis Pharma 65 HDAC Inhibitor 65 Tarvacin 65 therapeutic monoclonal antibody 65 Evoltra 65 TheraCIM 65 allosteric modulator 65 TPI ASM8 65 LEP ETU 65 maturation inhibitor 65 Azixa 65 MORAb 65 acetonide FA 65 tramiprosate Alzhemed TM 65 apoptosis inducer 65 SPRYCEL ® 65 Trastuzumab 65 Serdolect ® 65 Tarceva TM 65 atrasentan 65 nicotinic alpha 7 65 Urocidin TM 65 IMC #B 65 Bendamustine 65 orally bioavailable mimics 65 BioNumerik 65 Kahalalide F 65 radiation sensitizer 65 NOX E# 65 IMiD 65 MNTX 65 IAP inhibitors 65 Prodarsan R 65 anticoagulant reversing agent 65 Atiprimod 65 TELINTRA 65 alefacept 65 targeted antifolate 65 RPL# 65 polymerase inhibitor 65 GGF2 65 natriuretic peptide 65 sodium glucose cotransporter 65 immunotherapeutic agent 65 IGF IR 65 partial agonist 65 SEPET TM 65 Increlex R 65 FBPase 65 KIACTA ™ 65 Zybrestat 65 huN# DM1 65 histamine dihydrochloride 65 NPC 1C 65 Febuxostat 65 HGS ETR2 65 DPP4 65 Civacir 65 ANYARA 65 Zoraxel 65 EGFR tyrosine kinase inhibitors 65 ixabepilone 65 vinca alkaloid 65 Kamada AAT 65 alkylating agent 65 phase IIb 65 Onalta ™ 65 FLT3 65 prostone 65 novel histone deacetylase 65 Potelligent Technology 65 Unit Dose Budesonide 65 HDACi 65 immunotoxin 65 PDE# inhibitors 65 imexon 65 generation purine nucleoside 65 Tesmilifene 65 PEP# [003] 65 Xerecept 65 pharmacodynamic PD 65 LAF# 65 Ataluren 65 Fingolimod 65 generation antisense 65 Saxagliptin 65 refractory chronic lymphocytic 65 Chemokine Receptor 65 CVac 65 Phase IIB 65 mTOR inhibitor 65 Aurora kinase inhibitor 65 volociximab 65 alagebrium 65 GSK# [001] 65 fibrotic disease 65 Arimoclomol 65 Deforolimus 65 Zorbtive TM 65 Phase IIb trials 65 Exelixis XL# 65 Crofelemer 65 CD3 monoclonal antibody 65 lixivaptan 65 Yondelis ® 65 RGB # 65 TASQ 65 Vegenics 65 BLA filing 65 novel anticancer 65 acyclovir Lauriad ® 65 Pemetrexed 65 RTP #i 65 Cethrin R 65 TYZEKA 65 Evoltra TM 65 GMX# 65 signal transduction inhibitor 65 multiple myeloma MM 65 compound INCB# 65 milatuzumab 65 siRNA therapeutics 65 investigational monoclonal antibody 65 IFN α 65 tezampanel 65 TLR9 agonist 65 valopicitabine 65 UVIDEM 65 M2 subunit 65 Anticalin 65 oral antiviral 65 p# inhibitor 65 oral talactoferrin 65 PREOS R 65 AVN# [001] 65 Chemophase 65 IMiDs ® compound 65 Octreotide 65 Phase IIb III 65 Pivotal Phase III 65 alpha#beta# integrin 65 Urocidin 65 fipamezole 65 torezolid phosphate 65 Decitabine 65 custirsen 65 hematological indications 64 Anticalin R 64 Nanobodies 64 biliary tract cancer 64 OX1 64 MGd 64 fusion inhibitor 64 injectable formulation 64 Angiolix 64 BRIM2 64 Seliciclib 64 rhIGF-I/rhIGFBP-3 64 ARIKACE 64 Fibrillex 64 Preclinical studies suggest 64 HDAC inhibition 64 MKC# MT 64 Sphingomab TM 64 Enkephalin 64 Anavex #-# 64 DOS# 64 Cx# [002] 64 ADAGIO study 64 Raptiva ® 64 tyrosine kinase inhibitor 64 RIGScan CR 64 delipidation 64 IIa trial 64 Natalizumab 64 SERMs 64 myeloproliferative diseases 64 canakinumab 64 Milnacipran 64 edifoligide 64 Abiraterone 64 VNP#M 64 BENLYSTA ® 64 Tesetaxel 64 Triapine 64 EGFR HER2 64 belinostat 64 tafamidis 64 Tamibarotene 64 anti CD3 monoclonal 64 ANG# 64 myelofibrosis polycythemia vera 64 alpha antagonist 64 urocortin 2 64 Sutent sunitinib 64 IMiDs ® 64 Prosaptide 64 receptor inhibitor 64 phase Ib clinical 64 confirmatory Phase III 64 antiangiogenic agent 64 sulodexide 64 aleglitazar 64 trastuzumab DM1 T DM1 64 Lisofylline LSF 64 SUTENT 64 EGFR HER 64 Phase 2b trial 64 olaparib 64 adrenergic regulation 64 Nanobody R 64 trabedersen 64 vinorelbine tartrate 64 Anturol TM 64 davunetide intranasal AL 64 Carfilzomib 64 FGFR 64 lintuzumab 64 HyACT 64 PDX pralatrexate 64 ThGRF 64 dasatinib Sprycel 64 VEGF receptor 64 zileuton 64 RezularTM 64 Antiangiogenic 64 Zingo TM 64 unoprostone isopropyl 64 cathepsin K inhibitor 64 SUTENT ® 64 Phase #/#a 64 antibody fragment 64 Atrasentan 64 Maribavir 64 Cannabinor 64 Elocalcitol 64 CYC# 64 goserelin 64 talabostat 64 posaconazole 64 SRT# [003] 64 STRIDE PD 64 Dynepo 64 refractory prostate cancer 64 pharmacological chaperone 64 Silodosin 64 ChronVac C R 64 teplizumab 64 SYN# 64 DermaVir Patch 64 lenalidomide Revlimid 64 lipid nanoparticle 64 menadione 64 Aptivus ® 64 SERCA2a 64 amrubicin 64 phase IIb study 64 malignant ascites 64 PF # [001] 64 OMAPRO ™ 64 Junovan TM 64 Recombinant Human 64 ZOLINZA 64 paclitaxel poliglumex 64 Interferon alpha 64 Vorinostat 64 galiximab 64 CAMPATH 64 P#X# antagonist 64 evaluating satraplatin 64 Uvidem 64 Phase III psoriasis 64 MAXY VII 64 phase 2a 64 BioSilicon 64 prucalopride 64 HGS# 64 ProLindac TM 64 Trastuzumab DM1 64 tranilast 64 Quinamed 64 Phase 2b clinical trials 64 TRIST study 64 IPL# 64 mu opioid receptor antagonist 64 torsemide ER 64 intravesical infusion therapy 64 K RAS 64 mifamurtide 64 vismodegib 64 ALN HPN 64 kallikrein 64 hormone agonist 64 PGL# 64 Indaflex TM 64 BrachySil ™ 64 demonstrated antitumor activity 64 renin inhibitors 64 Fentanyl TAIFUN R 64 anti CD3 64 Vectibix panitumumab 64 velafermin 64 BRAF inhibitors 64 Myolimus 64 gepirone ER 64 KB# [002] 64 gamma secretase inhibitor 64 InterfeRx 64 LB# [003] 64 evaluating tivozanib 64 dexanabinol 64 XL# XL# 64 trastuzumab Herceptin 64 novel peptides 64 opioid induced bowel dysfunction 64 sodium glucose transporter 64 OncoVEX 64 Maraviroc 64 Familial Adenomatous Polyposis FAP 64 small molecule thrombopoietin 64 CB1 antagonists 64 EDEMA3 trial 64 Anticalin ® 64 nitric oxide donating 64 plasma kallikrein 64 apricitabine 64 telomerase therapeutic 64 Romidepsin 64 Cimzia TM 64 rhMBL 64 G#DT 64 orally inhaled 64 Angiocept 64 trial evaluating PRX# 64 Onalta TM 64 omecamtiv mecarbil 64 drug conjugate 64 talactoferrin 64 PROMACTA 64 LEUKINE 64 MTP inhibitor 64 BEMA TM Fentanyl 64 BXT # 64 Æterna Zentaris 64 CYT# 64 metastatic castration resistant 64 Arikace 64 INCB# [003] 64 PEGylated 64 Cethromycin 64 muraglitazar 64 JAK3 64 Vicinium TM 64 Pancreate 64 RH1 64 Cleviprex TM clevidipine 64 DCVax R 64 GRNVAC1 64 XmAb 64 enzyme inhibitor 64 Microplasmin 64 daclizumab 64 Olmesartan 64 Phase III randomized controlled 64 danoprevir 64 oxaliplatin Eloxatin 64 Phase 2b Clinical Trial 64 mesylate 64 LY# [002] 64 alemtuzumab Campath 64 delafloxacin 64 miR #a [002] 64 gemcitabine Gemzar ® 64 Campath alemtuzumab 64 investigational immunotherapy 64 PLX# 64 effector function 64 ACZ# 64 NexACT 64 PRX# 64 p# mitogen activated 64 Allovectin 7 R 64 Lodotra 64 Valdoxan 64 #I TM# 64 myeloproliferative disorders 64 ONCONASE R 64 antiangiogenesis 64 relapsed ovarian cancer 64 Phase 2a 64 Curaxin 64 antisense inhibitors 64 virus HCV protease inhibitor 64 inhaled formulation 64 silodosin 64 GFT# 64 epigenetic therapies 64 Targeted Chemotherapy 64 uric acid lowering 64 adecatumumab 64 resolvins 64 pafuramidine maleate 64 dose escalation clinical 64 randomized Phase IIb 64 peripherally acting 64 oral ridaforolimus 64 relapsed MM 64 alpha folate receptor 64 Vidofludimus 64 Hedgehog Pathway Inhibitor 64 sorafenib Nexavar 64 apoptosis proteins 64 Sudhir Agrawal D.Phil 64 VitiGam TM 64 Ixempra 63 Myelodysplastic Syndrome MDS 63 Phase 1b trial 63 CIMZIA R 63 anti CD# monoclonal 63 SILENOR 63 AtuRNAi 63 EFAPROXYN 63 Omapro 63 etanercept Enbrel 63 sphingosine 1 63 trastuzumab Herceptin ® 63 Valopicitabine 63 LHRH antagonists 63 RAF kinase 63 PDE4 63 interferon IFN 63 JP-#/fipamezole 63 ProLindac 63 Zolinza 63 liprotamase 63 Tumour Vascular Disrupting Agent 63 HCV NS5B polymerase 63 Epidermal Growth Factor Receptor 63 Nanobodies ® 63 zanolimumab 63 oral methylnaltrexone 63 AZILECT R